心脏手术患者合并COVID-19的病例系列报告
该病例系列描述了心脏手术后感染SARS-CoV-2的20例患者特征、术后病程及实验室检查结果,并报告医护人员感染情况。患者平均年龄69±10.4岁,术后至诊断中位时间15天,总体死亡率15%。作者指出体外循环后全身炎症状态可能掩盖典型COVID-19实验室表现,需重组医院资源以安全恢复手术。
要点
- 心脏手术后感染SARS-CoV-2总体死亡率15%,症状特异性表现仅占35%。
- 体外循环后炎症状态可能掩盖典型COVID-19实验室特征,增加诊断难度。
- 需严格重组医院资源以安全恢复心脏外科手术活动。
核心结论
- 心脏手术后感染COVID-19无论发病时间如何均为严重状况。
- 体外循环后全身炎症状态可能掩盖典型COVID-19实验室表现,使诊断更困难。
- 需要严格重组医院资源以安全恢复心脏外科手术活动。
研究设计与样本
- 病例系列报告,在心脏外科单元发生SARS-CoV-2暴发后,对所有患者和医护人员进行鼻咽拭子检测。
- 20例心脏手术后SARS-CoV-2阳性患者被隔离并监测至出院后死亡或临床康复。
- 同时描述12名感染医护人员的结局。
主要发现
- 20例患者平均年龄69±10.4岁,中位EuroSCORE II评分3(四分位距5.1)。
- 手术至诊断中位时间15天(四分位距11)。
- 18例接受心脏手术,2例接受经导管主动脉瓣置换。
- 总体死亡率15%。
- 7例(35%)出现特异性COVID-19相关症状;12名感染医护人员中1例出现双侧轻度间质性肺炎。
临床怎么用
- 心脏手术后患者应警惕COVID-19感染,即使缺乏典型症状也需检测。
- 体外循环术后炎症状态可能干扰COVID-19实验室诊断,需结合临床综合判断。
- 暴发后应暂停手术、全面筛查,并重组资源以安全恢复手术活动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The impact of coronavirus disease 2019 (COVID-19) on the postoperative course of patients after cardiac surgery is unknown. We experienced a major severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in our cardiac surgery unit, with several patients who tested positive early after surgery. Here we describe the characteristics, postoperative course, and laboratory findings of these patients, along with the fate of the health care workers. We also discuss how we reorganize and reallocate hospital resources to resume the surgical activity without further positive patients. METHODS: After diagnosis of the first symptomatic patient, surgery was suspended. Nasopharyngeal swabs were performed in all patients and health care workers. Patients who were positive for SARS-CoV-2 were isolated and monitored throughout the in-hospital stay and followed up after discharged until death or clinical recovery. RESULTS: Twenty patients were found to be positive for SARS-CoV-2 sometime after cardiac surgery (mean age 69 ± 10.4 years; median European System for Cardiac Operative Risk Evaluation II score 3 [interquartile range, 5.1]); the median time from surgery to diagnosis was 15 days (interquartile range, 11). Among the patients, 18 had undergone cardiac surgery and 2 of them transcatheter aortic valve replacement. Overall mortality was 15%. Specific COVID-19-related symptoms were identified in 7 patients (35%). Among the 12 health care workers infected, 1 developed a bilateral mild-grade interstitial pneumonia. CONCLUSIONS: COVID-19 infection after cardiac surgery, regardless the time of the onset, is a serious condition. The systemic inflammatory state that follows extracorporeal circulation may mask the typical COVID-19 laboratory findings, making the diagnosis more difficult. A strict reorganization of the hospital resources is necessary to safely resume the cardiac surgical activity.
引用
- Fattouch K, Corrao S, Augugliaro E, et al. Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): A case-series report. J Thorac Cardiovasc Surg. 2020. PMID: 33220960. doi:10.1016/j.jtcvs.2020.09.138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。